Latest Intelligence on Pharmaceuticals

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

BMS fails to fight off generic competition for Taxol

Published By Datamonitor
15 Sep 2000
CommentWire
CommentWire

Eli Lilly: cheeky but risky insulin strategy

Published By Datamonitor
19 Sep 2000
Expert View
Expert View

Waste not, want not: drug delivery to the rescue

Published By Datamonitor
22 Sep 2000
CommentWire
CommentWire

Alza: a new focus on in-house development

Published By Datamonitor
06 Oct 2000
Expert View
Expert View

From pens to transplants: what next for insulin?

Published By Datamonitor
06 Oct 2000
CommentWire
CommentWire

Cephalon/Anesta: painful times could be ahead

Published By Datamonitor
12 Oct 2000
CommentWire
CommentWire

Pfizer: more pressure on inhaled insulins

Published By Datamonitor
16 Oct 2000
Expert View
Expert View

Bye bye blockbuster!

Published By Datamonitor
20 Oct 2000
Expert View
Expert View

Compliance is just a click away

Published By Datamonitor
03 Nov 2000
CommentWire
CommentWire

Flu remedies: out in the cold

Published By Datamonitor
08 Nov 2000

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.